48 results
8-K
EX-99.2
KRYS
Krystal Biotech Inc
26 Jul 23
Krystal Biotech Announces Pipeline Expansion into Oncology
4:01pm
as of the date this presentation is given. Except as required by law, the Company disclaims any intention or responsibility for updating or revising any
8-K
EX-1.1
KRYS
Krystal Biotech Inc
8 May 23
Entry into a Material Definitive Agreement
8:51am
responsibility of the Company, and Cowen shall have no obligation in connection with such compliance. The issuance and sale of Common Stock through Cowen … the meaning of Investment Company Act.
(v) Insurance. The Company and its subsidiaries are insured by insurers of recognized financial responsibility
424B5
hhz 6sqmnn0bu
8 May 23
Prospectus supplement for primary offering
8:48am
8-K
EX-1.1
9f77 uwlku6v4b2qfg
3 Dec 21
Entry into a Material Definitive Agreement
4:05pm
424B2
6fvknggc
1 Dec 21
Prospectus for primary offering
5:27pm
424B5
4hlim1uul78
29 Nov 21
Prospectus supplement for primary offering
4:54pm